131 related articles for article (PubMed ID: 1459347)
1. Protective effect of human pancreatic secretory trypsin inhibitor on cerulein-induced acute pancreatitis in rats.
Funakoshi A; Miyasaka K; Jimi A; Kitani K; Teraoka H; Yoshida N
Digestion; 1992; 52(3-4):145-51. PubMed ID: 1459347
[TBL] [Abstract][Full Text] [Related]
2. The protective effects of long-acting recombinant human pancreatic secretory trypsin inhibitor (R44S-PSTI) in a rat model of cerulein-induced pancreatitis.
Chen YZ; Ikei S; Yamaguchi Y; Sameshima H; Sugita H; Moriyasu M; Ogawa M
J Int Med Res; 1996; 24(1):59-68. PubMed ID: 8674801
[TBL] [Abstract][Full Text] [Related]
3. The protective effect of the trypsin inhibitor urinastatin on cerulein-induced acute pancreatitis in rats.
Tani S; Otsuki M; Itoh H; Nakamura T; Fujii M; Okabayashi Y; Fujisawa T; Baba S
Pancreas; 1988; 3(4):471-6. PubMed ID: 2459695
[TBL] [Abstract][Full Text] [Related]
4. Transgenic expression of pancreatic secretory trypsin inhibitor-I ameliorates secretagogue-induced pancreatitis in mice.
Nathan JD; Romac J; Peng RY; Peyton M; Macdonald RJ; Liddle RA
Gastroenterology; 2005 Mar; 128(3):717-27. PubMed ID: 15765407
[TBL] [Abstract][Full Text] [Related]
5. Protection against chronic pancreatitis and pancreatic fibrosis in mice overexpressing pancreatic secretory trypsin inhibitor.
Nathan JD; Romac J; Peng RY; Peyton M; Rockey DC; Liddle RA
Pancreas; 2010 Jan; 39(1):e24-30. PubMed ID: 19904222
[TBL] [Abstract][Full Text] [Related]
6. Does somatostatin analogue prevent experimental acute pancreatitis?
Murayama KM; Drew JB; Joehl RJ
Arch Surg; 1990 Dec; 125(12):1570-2. PubMed ID: 2244811
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new cholecystokinin antagonist, TS-941, on experimental acute pancreatitis in rats.
Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T
Pancreas; 1998 Oct; 17(3):289-94. PubMed ID: 9788544
[TBL] [Abstract][Full Text] [Related]
8. Hormone-induced pancreatitis.
Willemer S; Elsässer HP; Adler G
Eur Surg Res; 1992; 24 Suppl 1():29-39. PubMed ID: 1601022
[TBL] [Abstract][Full Text] [Related]
9. Base variant of human pancreatic secretory trypsin inhibitor in healing of stress-induced gastric lesions in rats.
Konturek PCh; Brzozowski T; Konturek SJ; Taut A; Pierzchalski P; Elia G; Pajdo R; Yagi S; Hahn EG
Regul Pept; 1998 Oct; 77(1-3):95-103. PubMed ID: 9809802
[TBL] [Abstract][Full Text] [Related]
10. [Protective effect of prostaglandin E2 on cerulein-induced rat pancreatitis].
Ando K; Manabe T; Tobe T
Nihon Geka Hokan; 1992 May; 61(3):259-67. PubMed ID: 1444703
[TBL] [Abstract][Full Text] [Related]
11. Effect of the microtubule-disrupting drug colchicine on rat cerulein-induced pancreatitis in comparison with the microtubule stabilizer taxol.
Ueda T; Takeyama Y; Adachi M; Toyokawa A; Kishida S; Yamamoto M; Saitoh Y
Pancreas; 1995 Oct; 11(3):294-302. PubMed ID: 8577685
[TBL] [Abstract][Full Text] [Related]
12. Human urinary trypsin inhibitor, urinastatin, prevents pancreatic injuries induced by pancreaticobiliary duct obstruction with cerulein stimulation and systemic hypotension in the rat.
Hirano T; Manabe T
Arch Surg; 1993 Dec; 128(12):1322-9; discussion 1329. PubMed ID: 7504442
[TBL] [Abstract][Full Text] [Related]
13. Effects of green tea catechins (Polyphenon 100) on cerulein-induced acute pancreatitis in rats.
Takabayashi F; Harada N
Pancreas; 1997 Apr; 14(3):276-9. PubMed ID: 9094158
[TBL] [Abstract][Full Text] [Related]
14. Transgenic expression of pancreatic secretory trypsin inhibitor-1 rescues SPINK3-deficient mice and restores a normal pancreatic phenotype.
Romac JM; Ohmuraya M; Bittner C; Majeed MF; Vigna SR; Que J; Fee BE; Wartmann T; Yamamura K; Liddle RA
Am J Physiol Gastrointest Liver Physiol; 2010 Apr; 298(4):G518-24. PubMed ID: 20110462
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of a pancreatic elastase inhibitor against a variety of acute pancreatitis in rats.
Yamano M; Miyata K; Yamada T
Jpn J Pharmacol; 1998 Jul; 77(3):193-203. PubMed ID: 9717766
[TBL] [Abstract][Full Text] [Related]
16. Intrapancreatic turnover of recombinant human pancreatic secretory trypsin inhibitor in experimental porcine pancreatitis.
Jönsson P; Ohlsson K
Scand J Clin Lab Invest; 1995 May; 55(3):223-7. PubMed ID: 7638556
[TBL] [Abstract][Full Text] [Related]
17. Protective Effect of Pretreatment with Acenocoumarol in Cerulein-Induced Acute Pancreatitis.
Warzecha Z; Sendur P; Ceranowicz P; Dembiński M; Cieszkowski J; Kuśnierz-Cabala B; Olszanecki R; Tomaszewska R; Ambroży T; Dembiński A
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754317
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic phospholipase A2 in cerulein-induced acute pancreatitis in the rat.
Hietaranta AJ; Aho HJ; Nevalainen TJ
Int J Pancreatol; 1993 Dec; 14(3):261-7. PubMed ID: 8113628
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment with obestatin inhibits the development of cerulein-induced pancreatitis.
Ceranowicz P; Warzecha Z; Dembinski A; Cieszkowski J; Dembinski M; Sendur R; Kusnierz-Cabala B; Tomaszewska R; Kuwahara A; Kato I
J Physiol Pharmacol; 2009 Sep; 60(3):95-101. PubMed ID: 19826187
[TBL] [Abstract][Full Text] [Related]
20. Effect of urinary trypsin inhibitor on pancreatic cellular and lysosomal fragility in cerulein-induced acute pancreatitis in rats.
Hirano T; Manabe T; Tobe T
Dig Dis Sci; 1993 Apr; 38(4):660-4. PubMed ID: 7681748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
